Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Tools & Technology » Sequencing » Personalized Cancer Vaccines Demonstrate Potential in Melanoma Studies

Personalized Cancer Vaccines Demonstrate Potential in Melanoma Studies

Jul 05, 2017
|
staff reporter

NEW YORK (GenomeWeb) – A pair of new studies is pointing to the potential of personalized anti-cancer vaccine strategies in individuals with advanced melanoma.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Vaccine Supply Chain Hacker Warning

IBM security researchers warn of a phishing campaign targeted at organizations involved in the distribution of SARS-CoV-2 vaccines, the Verge reports.

Illinois Cuts Forensic Testing Backlog

The Illinois police have cut the number of DNA tests waiting to be run in about half, CBS Chicago reports.

Lying Plea

A researcher accused of smuggling research materials out of the US has pleaded guilty to making false statements, according to the Associated Press.

Science Studies on Nonalcoholic Fatty Liver Disease Expression Signatures, Ties Between Gut Microbiome and Major Depression

In Science this week: gene expression signature linked to nonalcoholic fatty liver disease progression, and more.

Dec
10
Featured Webinar

Accelerating Forward Engineering and Genome Discovery with CRISPR: E. Coli Case Studies

Sponsored by
Tecan

CRISPR has developed into a core tool to facilitate genome editing, inspiring transformative ideas in engineering biology. 

Dec
10
Featured Webinar

Five Things to Consider When Ordering NIPT

Sponsored by
Illumina

Numerous companies now offer non-invasive prenatal screening (testing), many on different technology platforms. 

What's Popular?

In Sequencing

  1. Ravgen Sues Illumina, Roche Alleging Infringement of Cell-Free DNA Testing Patents

  2. Illumina, New York Healthcare Providers, NYGC Partner on Clinical Whole-Genome Sequencing

  3. Oxford Nanopore Touts Tech Improvements Including PromethIon, Accuracy, Automation

    Premium

  4. Swedish Sequencing Firm Single Technologies Raises $6.1M

  5. Nonalcoholic Fatty Liver Disease Progression Can Be Traced by Gene Expression Signature

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.